Newman v. Bayer Corporation

District Court, S.D. New York·Decided December 2, 2024·No. 7:22-cv-07087·Unknown

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK -------------------------------------------------------------X TANYSHA NEWMAN, individually and on behalf of all others similarly situated,

Plaintiff, DECISION AND ORDER

-against- 22 Civ. 7087 (KMK) (AEK)

BAYER CORPORATION, et al.,

Defendants. -------------------------------------------------------------X

THE HONORABLE ANDREW E. KRAUSE, U.S.M.J. Plaintiff Tanysha Newman brings this case individually, and on behalf of all others similarly situated, asserting claims for breaches of express and implied warranties, deceptive trade practices, false advertising, and fraud against Defendants Bayer Corporation and Bayer Healthcare LLC (collectively, “Defendants”), based on the alleged mislabeling of their “One A Day” chewable supplements, which, according to the complaint, require consumers to take two or more supplements per day in order to get the full nutritional benefit. ECF No. 1 (Complaint). Before the Court is Defendants’ letter motion to compel the production of the responses to, and data from, a survey designed by one of Plaintiff’s experts. ECF No. 82 (“Defs.’ Mot.”). Plaintiff opposes the motion—she maintains that the expert never “considered” the information sought by Defendants, and therefore production is not required. ECF No. 83 (“Pl.’s Opp.”). For the reasons set forth below, the motion to compel is DENIED. BACKGROUND Plaintiff retained an expert, Robert Klein, to test whether consumers were confused by the name of Defendants’ One A Day gummy multivitamins. See Defs.’ Mot. Ex. A (“Klein Dep.”) at 21:8-14.1 Klein designed an initial survey for this purpose. At his deposition, Klein 0F testified that he ran the initial survey, got the results, and then “we”—which appears to be a reference to Klein’s colleagues at Applied Marketing Services, Inc. (“AMS”)—tabulated the results. Klein Dep. at 77:22-78:4. After the first survey was conducted, however, Plaintiff’s counsel asked Klein to conduct a second survey to address feedback from Plaintiff’s economic expert. See id. at 78:5-11 (“There was some discussion as to how well that survey fit with the economist’s calculation when he wanted to make them. And so, we constructed the second survey to better fit what he perceived his needs to be in the matter.”), 80:9-16, 312:24-313:2 (“Q. So counsel knew the results in the first survey, and then counsel asked you to do the second survey, right? A. I believe that’s correct. Yes.”).2 Klein relied on the results of the second 1F survey to form the basis of his expert opinion. Id. at 319:19-25. Defendants demanded the production of documents and information regarding the first survey, in particular the results and underlying data for Q3 – Q6. Defs.’ Mot. at 2. Plaintiff states that she has provided Defendants with: (i) the original survey instrument, which Klein was involved in drafting, see Pl.’s Opp. at 1; (ii) the percentages of survey respondents in the test and control groups who believed the bottle lasted for “150 days” and the net difference between these percentages, information that Klein learned during a telephone call with AMS personnel, see id. & ECF No. 83-1 (“Klein Decl.”) ¶ 6; and (iii) the total number of people who took the first

1 Klein testified that paragraph 11 of his report states, “I was asked by counsel for Plaintiff to design, conduct, and analyze a market research survey to determine whether a significant number of the relevant consumers are misled by the gummies, One A Day name, by understanding how many gummies they think are in a serving size.” Klein Dep. at 21:9-14. 2 When asked whether he told Plaintiff’s counsel the results of the first survey, Klein responded, “I think my colleagues did.” Klein Dep. at 312:21-23. survey, which, according to Plaintiff’s counsel, Klein never knew, see Pl.’s Opp. at 1 (citing Defs.’ Mot. Ex. C at p. 6). But Plaintiff maintains that any further production is not warranted. DISCUSSION Rule 26(a)(2)(B) of the Federal Rules of Civil Procedure provides that an expert witness

must disclose “the facts or data considered by the witness in forming” his or her opinions. Fed. R. Civ. P. 26(a)(2)(B)(ii). “[E]ven if the expert avers under oath that he [or she] did not actually consider certain materials in forming his [or her] opinion, that will not control, and instead courts apply an objective test that defines ‘considered’ as any facts or data on the subject matter learned by the expert at any time before rendering his [or her] opinion.” Seawolf Tankers Inc. v. Laurel Shipping LLC, No. 20-cv-5198 (JHR) (SDA), 2024 WL 532397, at *4 (S.D.N.Y. Feb. 9, 2024) (cleaned up). The word “considered” has been interpreted by courts to mean “anything received, reviewed, read, or authored by the expert, before or in connection with the forming of his [or her] opinion, if the subject matter relates to the facts or opinions expressed.” In re Mirena IUD Prod. Liab. Litig., 169 F. Supp. 3d 396, 470 (S.D.N.Y. 2016) (quotation marks omitted). “The burden

of showing that an expert did not consider certain documents in forming his [or her] opinion rests with the party resisting the disclosure.” Thieriot v. Jaspan Schlesinger Hoffman LLP, No. 07-cv- 5315 (TCP) (AKT), 2011 WL 4543308, at *4 (E.D.N.Y. Sept. 29, 2011). “Although an expert’s representation as to whether or not he [or she] considered a document is not controlling, his [or her] testimony that he [or she] did not receive, read, review or author a document will negate discovery absent persuasive evidence to the contrary.” Id. (quotation marks omitted). “The burden can be met when the party opposing disclosure provides the court with affidavits and deposition testimony clearly establishing that the testifying witness never read, reviewed, or considered the subject documents in forming his [or her] opinions.” Id. (quotation marks omitted). Defendants cite Klein’s deposition testimony that he “got the results” from the first survey and “tabulated” and “analyzed” them as demonstrating that he considered the results and

data obtained from the first survey. See Defs.’ Mot. at 3 (citing Klein Dep. at 69:15-23, 82:7-11, 319:10-18). But Klein’s deposition testimony is not as clear as Defendants make it out to be; rather, it is equivocal at best in establishing Klein’s personal involvement in reviewing and analyzing the results of the first survey. Klein’s references to what was done after the first survey was conducted are most plausibly understood to be references to work performed by Klein’s colleagues, not Klein himself. Thus, when he was asked, “[d]id you analyze the data,” Klein responded, “[w]e tabulated, yes.” Klein Dep. at 82:10-11 (emphasis added); see also id. at 69:15-20 (“Q. And you got the results for that survey, correct? A. Yes. Q. And you analyzed the results of that survey, right? A. We tabulated. Yes.”) (emphasis added). This is consistent with the declaration that Klein submitted in connection with this motion, where he described the

process more fully: “[a]fter the survey instrument was finalized, other employees of AMS carried out the survey while I was ‘walled off’ from the process. That means that I was not presented with or shown any individual responses to the survey (the underlying survey data) as they came in and would not be shown these responses unless and until the responses were finalized and the results were to be utilized.” Klein Decl. ¶ 4. Other deposition testimony cited by Defendants is also unclear when read in context.

Free access — add to your briefcase to read the full text and ask questions with AI

Newman v. Bayer Corporation, (S.D.N.Y. 2024).

Newman v. Bayer Corporation (Newman v. Bayer Corporation) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

In re Mirena IUD Products Liability Litigation
169 F. Supp. 3d 396 (S.D. New York, 2016)
Lee Valley Tools, Ltd. v. Industrial Blade Co.
288 F.R.D. 254 (W.D. New York, 2013)